Analysis of Changes in PINK1 in Patients with Diabetic Nephropathy and Its Relationship with Serum Factors and Clinical Indexes
International Journal of Clinical and Experimental Medicine Research · 03.03.2026 · 10 (2) · 91-95
DOI: 10.26855/ijcemr.2026.03.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical and Experimental Medicine Research, online erschienen am 03.03.2026. Verfasst von Dongmei Xu und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Objective
To investigate the changes in the protein kinase PINK1 in patients with diabetic nephropathy (DN) and to analyze its relationship with serum factors and clinical Indicators.
Methods
A total of 90 patients with DN treated between November 2023 and February 2025 were enrolled and randomly divided into three groups according to different treatment regimens, with 30 patients in each group. Patients receiving telmisartan alone were assigned to control group 1; those treated with metformin hydrochloride alone were assigned to control group 2; and patients in the observation group received combined treatment with metformin hydrochloride and telmisartan. Levels of PINK1, reactive oxygen species (ROS), renal function, and serum factors were compared among the three groups. Pearson correlation analysis was used to evaluate the relationships between PINK1 levels, serum creatinine, UACR, and serum factors in DN patients.
Results
After intervention, levels of ROS, serum creatinine, UACR, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) were decreased, while PINK1 and interleukin-2 (IL-2) levels were increased in all three groups. The observation group showed significantly higher PINK1 mRNA and IL-2 levels compared with control group 1 and control group 2 (P < 0.05), while levels of ROS, IL-6, and TNF-α were significantly lower (P < 0.05). Pearson correlation analysis demonstrated that PINK1 levels were positively correlated with IL-2 (P < 0.05) and negatively correlated with IL-6 and TNF-α (P < 0.05).
Conclusion
Combined treatment with metformin hydrochloride and telmisartan in DN patients can increase PINK1 and IL-2 levels and reduce ROS, serum creatinine, UACR, IL-6, and TNF-α levels. PINK1 is significantly correlated with serum factors and clinical Indicators, which may provide guidance for clinical diagnosis and treatment.
Zitieren
APA
Xu, D., Zeng, Z., Wang, B., Tang, D., & Hu, J. (2026). Analysis of Changes in PINK1 in Patients with Diabetic Nephropathy and Its Relationship with Serum Factors and Clinical Indexes. International Journal of Clinical and Experimental Medicine Research, 10(2), 91-95. https://doi.org/10.26855/ijcemr.2026.03.005
Vancouver
Xu D, Zeng Z, Wang B, Tang D, Hu J. Analysis of Changes in PINK1 in Patients with Diabetic Nephropathy and Its Relationship with Serum Factors and Clinical Indexes. International Journal of Clinical and Experimental Medicine Research. 2026;10(2):91-95. doi:10.26855/ijcemr.2026.03.005
BibTeX
@article{Xu2026,
author = {Xu, Dongmei and Zeng, Zhihong and Wang, Beibei and Tang, Dongyuan and Hu, Jiexi},
title = {Analysis of Changes in PINK1 in Patients with Diabetic Nephropathy and Its Relationship with Serum Factors and Clinical Indexes},
journal = {International Journal of Clinical and Experimental Medicine Research},
year = {2026},
volume = {10},
number = {2},
pages = {91--95},
doi = {10.26855/ijcemr.2026.03.005}
}
EUVIMED